
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other “Shock” Drugs
Erik Abner, Mateusz Stoszko, Lei Zeng, et al.
Journal of Virology (2018) Vol. 92, Iss. 10
Open Access | Times Cited: 52
Erik Abner, Mateusz Stoszko, Lei Zeng, et al.
Journal of Virology (2018) Vol. 92, Iss. 10
Open Access | Times Cited: 52
Showing 1-25 of 52 citing articles:
The Role of Macrophages in HIV-1 Persistence and Pathogenesis
Zita Kruize, Neeltje A. Kootstra
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 161
Zita Kruize, Neeltje A. Kootstra
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 161
Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
Amina Aït-Ammar, Anna Kula, Gilles Darcis, et al.
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 148
Amina Aït-Ammar, Anna Kula, Gilles Darcis, et al.
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 148
HIV “shock and kill” therapy: In need of revision
Erik Abner, Albert Jordan
Antiviral Research (2019) Vol. 166, pp. 19-34
Closed Access | Times Cited: 142
Erik Abner, Albert Jordan
Antiviral Research (2019) Vol. 166, pp. 19-34
Closed Access | Times Cited: 142
BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs
Patrícia Cristine Borck, Lian‐Wang Guo, Jorge Plutzky
Circulation Research (2020) Vol. 126, Iss. 9, pp. 1190-1208
Open Access | Times Cited: 120
Patrícia Cristine Borck, Lian‐Wang Guo, Jorge Plutzky
Circulation Research (2020) Vol. 126, Iss. 9, pp. 1190-1208
Open Access | Times Cited: 120
Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus
Lee Ann Campbell, Lamarque M. Coke, Christopher T. Richie, et al.
Molecular Therapy (2018) Vol. 27, Iss. 1, pp. 151-163
Open Access | Times Cited: 112
Lee Ann Campbell, Lamarque M. Coke, Christopher T. Richie, et al.
Molecular Therapy (2018) Vol. 27, Iss. 1, pp. 151-163
Open Access | Times Cited: 112
The Current Status of Latency Reversing Agents for HIV-1 Remission
Anthony Rodari, Gilles Darcis, Carine Van Lint
Annual Review of Virology (2021) Vol. 8, Iss. 1, pp. 491-514
Open Access | Times Cited: 99
Anthony Rodari, Gilles Darcis, Carine Van Lint
Annual Review of Virology (2021) Vol. 8, Iss. 1, pp. 491-514
Open Access | Times Cited: 99
Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs
Ivan Sadowski, Farhad B. Hashemi
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 18, pp. 3583-3600
Open Access | Times Cited: 98
Ivan Sadowski, Farhad B. Hashemi
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 18, pp. 3583-3600
Open Access | Times Cited: 98
Quercetin Blocks Ebola Virus Infection by Counteracting the VP24 Interferon-Inhibitory Function
Elisa Fanunza, Mathieu Iampietro, Simona Distinto, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 7
Open Access | Times Cited: 53
Elisa Fanunza, Mathieu Iampietro, Simona Distinto, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 7
Open Access | Times Cited: 53
Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies
Tram M. Ta, Sajjaf Malik, Elizabeth M. Anderson, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 35
Tram M. Ta, Sajjaf Malik, Elizabeth M. Anderson, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 35
Enhancing HIV-1 latency reversal through regulating the elongating RNA Pol II pause-release by a small-molecule disruptor of PAF1C
Shimaa Soliman, William J. Cisneros, Marta Iwanaszko, et al.
Science Advances (2023) Vol. 9, Iss. 10
Open Access | Times Cited: 15
Shimaa Soliman, William J. Cisneros, Marta Iwanaszko, et al.
Science Advances (2023) Vol. 9, Iss. 10
Open Access | Times Cited: 15
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 13
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 13
A high-throughput, microplate reader-based method to monitor in vitro HIV latency reversal in the absence of flow cytometry
Chantal Emade Nkwelle, Unique Stephens, Kimberly Liang, et al.
Virology (2025) Vol. 604, pp. 110418-110418
Closed Access
Chantal Emade Nkwelle, Unique Stephens, Kimberly Liang, et al.
Virology (2025) Vol. 604, pp. 110418-110418
Closed Access
Latency Reversing Agents and the Road to a HIV Cure
Louis Tioka, Rafael Ceña-Díez, Anders Sönnerborg, et al.
Pathogens (2025) Vol. 14, Iss. 3, pp. 232-232
Open Access
Louis Tioka, Rafael Ceña-Díez, Anders Sönnerborg, et al.
Pathogens (2025) Vol. 14, Iss. 3, pp. 232-232
Open Access
Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2
Elisa Fanunza, Fabrizio Carletti, Marina Quartu, et al.
Virulence (2021) Vol. 12, Iss. 1, pp. 1580-1596
Open Access | Times Cited: 30
Elisa Fanunza, Fabrizio Carletti, Marina Quartu, et al.
Virulence (2021) Vol. 12, Iss. 1, pp. 1580-1596
Open Access | Times Cited: 30
A broad drug arsenal to attack a strenuous latent HIV reservoir
Mateusz Stoszko, Enrico Ne, Erik Abner, et al.
Current Opinion in Virology (2019) Vol. 38, pp. 37-53
Open Access | Times Cited: 34
Mateusz Stoszko, Enrico Ne, Erik Abner, et al.
Current Opinion in Virology (2019) Vol. 38, pp. 37-53
Open Access | Times Cited: 34
Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies
Aurélie Delannoy, Mikaël Poirier, Brendan Bell
Viruses (2019) Vol. 11, Iss. 3, pp. 269-269
Open Access | Times Cited: 31
Aurélie Delannoy, Mikaël Poirier, Brendan Bell
Viruses (2019) Vol. 11, Iss. 3, pp. 269-269
Open Access | Times Cited: 31
Diversity of small molecule HIV‐1 latency reversing agents identified in low‐ and high‐throughput small molecule screens
Pargol Hashemi, Ivan Sadowski
Medicinal Research Reviews (2019) Vol. 40, Iss. 3, pp. 881-908
Open Access | Times Cited: 27
Pargol Hashemi, Ivan Sadowski
Medicinal Research Reviews (2019) Vol. 40, Iss. 3, pp. 881-908
Open Access | Times Cited: 27
Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure
Edrous Alamer, Chaojie Zhong, Renee L. Hajnik, et al.
Retrovirology (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Edrous Alamer, Chaojie Zhong, Renee L. Hajnik, et al.
Retrovirology (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 22
INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation
Elisa Fanunza, Nicole Grandi, Marina Quartu, et al.
Viruses (2021) Vol. 13, Iss. 12, pp. 2448-2448
Open Access | Times Cited: 22
Elisa Fanunza, Nicole Grandi, Marina Quartu, et al.
Viruses (2021) Vol. 13, Iss. 12, pp. 2448-2448
Open Access | Times Cited: 22
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency
Mateusz Stoszko, Abdullah M. S. Al‐Hatmi, Anton Škríba, et al.
Science Advances (2020) Vol. 6, Iss. 33
Open Access | Times Cited: 21
Mateusz Stoszko, Abdullah M. S. Al‐Hatmi, Anton Škríba, et al.
Science Advances (2020) Vol. 6, Iss. 33
Open Access | Times Cited: 21
Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression
Emmanuelle Wilhelm, Mikaël Poirier, Morgane Da Rocha, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 5, pp. e1011821-e1011821
Open Access | Times Cited: 2
Emmanuelle Wilhelm, Mikaël Poirier, Morgane Da Rocha, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 5, pp. e1011821-e1011821
Open Access | Times Cited: 2
Specific ActivationIn Vivoof HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy
Guangming Li, Zheng Zhang, Natalia Reszka-Blanco, et al.
Journal of Virology (2019) Vol. 93, Iss. 12
Open Access | Times Cited: 22
Guangming Li, Zheng Zhang, Natalia Reszka-Blanco, et al.
Journal of Virology (2019) Vol. 93, Iss. 12
Open Access | Times Cited: 22
Alphaherpesvirus Latency and Reactivation with a Focus on Herpes Simplex Virus
Nancy Sawtell, Richard Thompson
Current Issues in Molecular Biology (2020), pp. 267-356
Open Access | Times Cited: 15
Nancy Sawtell, Richard Thompson
Current Issues in Molecular Biology (2020), pp. 267-356
Open Access | Times Cited: 15
HIV latency reversal agents: A potential path for functional cure?
Juliana Romano Lopes, Diego Eidy Chiba, Jean Leandro dos Santos
European Journal of Medicinal Chemistry (2021) Vol. 213, pp. 113213-113213
Closed Access | Times Cited: 14
Juliana Romano Lopes, Diego Eidy Chiba, Jean Leandro dos Santos
European Journal of Medicinal Chemistry (2021) Vol. 213, pp. 113213-113213
Closed Access | Times Cited: 14
Isoform-Selective Versus Nonselective Histone Deacetylase Inhibitors in HIV Latency Reversal
Anthony Twumasi Boateng, Araba Abaidoo-Myles, Evelyn Yayra Bonney, et al.
AIDS Research and Human Retroviruses (2022) Vol. 38, Iss. 8, pp. 615-621
Open Access | Times Cited: 8
Anthony Twumasi Boateng, Araba Abaidoo-Myles, Evelyn Yayra Bonney, et al.
AIDS Research and Human Retroviruses (2022) Vol. 38, Iss. 8, pp. 615-621
Open Access | Times Cited: 8